Greece receives 5,700 treatments of molnupiravir for Covid-19, expects another 25,000 soon

ΣΧΕΤΙΚΑ ΑΡΘΡΑ

Επιπρόσθετα οφέλη από το αντιικό χάπι της Merck για τους ασθενείς Covid-19: Τι έδειξε αμερικανική μελέτη

Αυξήθηκαν οι θάνατοι σε 72 μειώθηκαν οι διασωληνωμένοι στους 499 σε σχέση με το Σαββάτο: 10.853 νέα κρούσματα

Κύπρος: Μειώνεται η καραντίνα για όσους αποτελούν στενές επαφές επιβεβαιωμένου κρούσματος

Greece has received 5,700 treatments of molnupiravir for Covid-19, Alternate Health Minister Mina Gaga told Athens-Macedonian News Agency on Saturday.

Another 25,000 treatments will also be received, after an approval by the European Medicines Agency (EMA) which is expected next month, she added.

This treatment has already been licensed for emergency use by the US Food & Drug Administration (FDA), she noted. In Greece, the treatment can be granted with the patients’ written consent, until the European approval process is completed.

Gaga explained that “at this stage of the pandemic, the Omicron mutation is predominant, and according to international scientific data it is not sensitive to treatment with monoclonal antibodies, which were administered to patients infected with the Delta mutation, with positive results. Therefore, the international scientific community is turning to oral therapies.”

Source: ANA – MPA

Pasteur Institute to create Greece’s first vaccines production facility